References

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005 Jan 15;365(9455):217-23. PubMed | Google Scholar

  2. Khor GL. Cardiovascular epidemiology in the Asia-Pacific region. Asia Pac J Clin Nutr. 2001;10(2):76-80. PubMed | Google Scholar

  3. Seedat YK. Recommendations for hypertension in sub-Saharan Africa. Cardiovasc J South Afr Off J South Afr Card Soc South Afr Soc Card Pract. 2004 Aug;15(4):157-8. PubMed | Google Scholar

  4. Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, Stichele RV, Van Bortel LM. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens. 2011 Jul;29(7):1243-52. PubMed | Google Scholar

  5. Muna WFT. Comprehensive strategies for the prevention and control of diabetes and cardiovascular diseases in Africa: future directions. Prog Cardiovasc Dis. 2013 Dec;56(3):363-6. PubMed | Google Scholar

  6. Ogah OS, Rayner BL. Recent advances in hypertension in sub-Saharan Africa. Heart Br Card Soc. 2013 Oct;99(19):1390-7. PubMed | Google Scholar

  7. Abir-Khalil S, Zaîmi S, Tazi MA, Bendahmane S, Bensaoud O, Benomar M. Prevalence and predictors of white-coat hypertension in a large database of ambulatory blood pressure monitoring. East Mediterr Health J Rev. 2009 Apr;15(2):400-7. PubMed | Google Scholar

  8. Nice clinical guidelines 127. Clinical Management of Primary Hypertension in adults. British Hypertension Society. 2011. Google Scholar

  9. Hwang E-S, Choi K-J, Kang D-H, Nam G-B, Jang J-S, Jeong Y-H, et al. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients. Korean J Intern Med. 2007 Dec;22(4):256-62. PubMed | Google Scholar

  10. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, et al. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 2010;340:c1104. PubMed | Google Scholar

  11. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995 Dec;13(12 Pt 1):1377-90. PubMed | Google Scholar

  12. Dolan E, Stanton A, Atkins N, Den Hond E, Thijs L, McCormack P, et al. Determinants of white-coat hypertension. Blood Press Monit. 2004 Dec;9(6):307-9. PubMed | Google Scholar

  13. Godil SS, Tabani H, Khan AH, Almas A. White coat hypertension is not a benign entity: a cross-sectional study at a tertiary care hospital in Pakistan. JPMA J Pak Med Assoc. 2011 Sep;61(9):938-43. PubMed | Google Scholar

  14. Den Hond E, Celis H, Vandenhoven G, O'Brien E, Staessen JA, THOP investigators. Determinants of white-coat syndrome assessed by ambulatory blood pressure or self-measured home blood pressure. Blood Press Monit. 2003 Feb;8(1):37-40. PubMed | Google Scholar

  15. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. In clinical practice, masked hypertension is as common as isolated clinic hypertension: predominance of younger men. Am J Hypertens. 2005 May;18(5 Pt 1):589-93. PubMed | Google Scholar

  16. Ben-Dov IZ, Mekler J, Ben-Arie L, Bursztyn M. Lack of association between body-mass index and white-coat hypertension among referred patients. Blood Press Monit. 2007 Apr;12(2):95-9. PubMed | Google Scholar

  17. Mansoor GA, McCabe EJ, White WB. Determinants of the white-coat effect in hypertensive subjects. J Hum Hypertens. 1996 Feb;10(2):87-92. PubMed | Google Scholar

  18. Acharya DU, Heber ME, Doré CJ, Raftery EB. Ambulatory intraarterial blood pressure in essential hypertension: Effects of age, sex, race, and body mass--the Northwick Park Hospital Database Study. Am J Hypertens. 1996 Oct;9(10 Pt 1):943-52. PubMed | Google Scholar

  19. Sabater-Hernández D, Sánchez-Villegas P, García-Corpas JP, Amariles P, Sendra-Lillo J, Faus MJ. Predictors of the community pharmacy white-coat effect in treated hypertensive patients: The MEPAFAR study. Int J Clin Pharm. 2011 Jun;33(3):582-9. PubMed | Google Scholar